Mankind Pharma Q1 results: Profit rises 10% to ₹543 cr; revenue up 12%
The revenue from domestic business grew 9% YoY to ₹2,634 cr in Q1 FY25, while exports rose 62% YoY to ₹259 cr
The revenue from domestic business grew 9% YoY to ₹2,634 cr in Q1 FY25, while exports rose 62% YoY to ₹259 cr
The pharma major reported 66% YoY growth in net profit at ₹494 crore, while sales rose 18% YoY to ₹2,579 crore in Q1FY24.